share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MCKENZIE DIANA

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MCKENZIE DIANA

福泰製藥 | 4:持股變動聲明-董事 MCKENZIE DIANA
美股SEC公告 ·  05/03 16:23

Moomoo AI 已提取核心訊息

On May 1, 2024, Diana McKenzie, associated with Vertex Pharmaceuticals Inc. (VRTX), engaged in transactions involving the company's common stock. McKenzie acquired 1,001 shares at no cost, which is typically indicative of a grant or award. On the same day, she disposed of 1,168 shares; however, the transaction price was not disclosed. Following these transactions, McKenzie's direct holdings in Vertex Pharmaceuticals totaled 2,436 shares. Additionally, it was reported that McKenzie holds 207 shares indirectly through a trust. The transactions have been marked as completed.
On May 1, 2024, Diana McKenzie, associated with Vertex Pharmaceuticals Inc. (VRTX), engaged in transactions involving the company's common stock. McKenzie acquired 1,001 shares at no cost, which is typically indicative of a grant or award. On the same day, she disposed of 1,168 shares; however, the transaction price was not disclosed. Following these transactions, McKenzie's direct holdings in Vertex Pharmaceuticals totaled 2,436 shares. Additionally, it was reported that McKenzie holds 207 shares indirectly through a trust. The transactions have been marked as completed.
2024年5月1日,與Vertex Pharmicals Inc.(VRTX)關聯的戴安娜·麥肯齊參與了涉及該公司普通股的交易。麥肯齊免費收購了1,001股股票,這通常表示授予或獎勵。同一天,她出售了1,168股股票;但是,交易價格沒有披露。這些交易之後,麥肯齊在Vertex Pharmicals的直接持股總額爲2436股。此外,據報道,麥肯齊通過信託間接持有207股股票。交易已標記爲已完成。
2024年5月1日,與Vertex Pharmicals Inc.(VRTX)關聯的戴安娜·麥肯齊參與了涉及該公司普通股的交易。麥肯齊免費收購了1,001股股票,這通常表示授予或獎勵。同一天,她出售了1,168股股票;但是,交易價格沒有披露。這些交易之後,麥肯齊在Vertex Pharmicals的直接持股總額爲2436股。此外,據報道,麥肯齊通過信託間接持有207股股票。交易已標記爲已完成。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息